AI Portfolio Summary
In 2025 Q4, venBio Partners LLC maintained a portfolio of 6 distinct positions. The fund also reduced its exposure to ARTIVA BIOTHERAPEUTI by 43.6%.
Total Positions
6
Quarter
2025 Q4
Top Holding
PHVS (59.5%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-6 of 6
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PHVS
PHARVARIS N V
|
Healthcare | 59.53% | 65.62% |
#1
Prev: #1
|
10.0 | no change | no change |
P
S
|
4,639,304 | $128,740,686 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALMS
ALUMIS INC
|
Healthcare | 20.85% | 10.45% |
#2
Prev: #2
|
8.3 | no change | no change |
P
S
|
4,619,803 | $45,089,277 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 8.46% | 7.64% |
#3
1
Prev: #4
|
3.4 | no change | no change |
P
S
|
489,194 | $18,305,639 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALXO
ALX ONCOLOGY HL...
|
Healthcare | 5.07% | 10.06% |
#4
1
Prev: #3
|
2.0 | no change | no change |
P
S
|
9,699,925 | $10,960,915 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LYEL
LYELL IMMUNOPHA...
|
Healthcare | 4.81% | 4.36% |
#5
Prev: #5
|
2.0 | -135,782 | -28.7% |
P
S
|
337,697 | $10,394,314 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 1.29% | 1.87% |
#6
Prev: #6
|
0.6 | -500,468 | -43.6% |
P
S
|
648,507 | $2,782,095 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-6 of 6 holdings